Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report

Brolucizumab a humanized single-chain antibody fragment targeting VEGF-A is approved for neovascular age-related macular degeneration nAMD and is being studied for other retinal conditions including polypoidal choroidal vasculopathy PCV. This case report presents a 79-year-old I...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohan S, Kalpana Badami, Shilpa Y D, Hemalata B C
Format: Article
Language:English
Published: Rajiv Gandhi University of Health Sciences 2025-01-01
Series:RGUHS Journal of Medical Sciences
Online Access:https://journalgrid.com/view/article/rjms/12434377
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203997783195648
author Mohan S
Kalpana Badami
Shilpa Y D
Hemalata B C
author_facet Mohan S
Kalpana Badami
Shilpa Y D
Hemalata B C
author_sort Mohan S
collection DOAJ
description Brolucizumab a humanized single-chain antibody fragment targeting VEGF-A is approved for neovascular age-related macular degeneration nAMD and is being studied for other retinal conditions including polypoidal choroidal vasculopathy PCV. This case report presents a 79-year-old Indian male with idiopathic PCV in the right eye characterized by diminished vision and a large serous pigment epithelial detachment PED 1092 mum. He was treated with a pro re nata PRN regimen of intravitreal Brolucizumab 6 mg0.05 ml. After the first injection PED reduced to 68 mum but later resurfaced 423 mum requiring a second injection. Subsequent follow-ups showed fluctuations in fluid levels necessitating a third injection after which complete resolution was observed. This case highlights Brolucizumabrsquos effectiveness in managing serous PED in IPCV with repeated administration improving long-term fluid resolution.
format Article
id doaj-art-9142699db934422eaeb277064c79f5e1
institution OA Journals
issn 2231-1947
2581-7248
language English
publishDate 2025-01-01
publisher Rajiv Gandhi University of Health Sciences
record_format Article
series RGUHS Journal of Medical Sciences
spelling doaj-art-9142699db934422eaeb277064c79f5e12025-08-20T02:11:22ZengRajiv Gandhi University of Health SciencesRGUHS Journal of Medical Sciences2231-19472581-72482025-01-0115210.26463/rjms.15_2_2Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case ReportMohan SKalpana BadamiShilpa Y DHemalata B C Brolucizumab a humanized single-chain antibody fragment targeting VEGF-A is approved for neovascular age-related macular degeneration nAMD and is being studied for other retinal conditions including polypoidal choroidal vasculopathy PCV. This case report presents a 79-year-old Indian male with idiopathic PCV in the right eye characterized by diminished vision and a large serous pigment epithelial detachment PED 1092 mum. He was treated with a pro re nata PRN regimen of intravitreal Brolucizumab 6 mg0.05 ml. After the first injection PED reduced to 68 mum but later resurfaced 423 mum requiring a second injection. Subsequent follow-ups showed fluctuations in fluid levels necessitating a third injection after which complete resolution was observed. This case highlights Brolucizumabrsquos effectiveness in managing serous PED in IPCV with repeated administration improving long-term fluid resolution.https://journalgrid.com/view/article/rjms/12434377
spellingShingle Mohan S
Kalpana Badami
Shilpa Y D
Hemalata B C
Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
RGUHS Journal of Medical Sciences
title Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
title_full Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
title_fullStr Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
title_full_unstemmed Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
title_short Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
title_sort brolucizumab monotherapy in idiopathic polypoidal choroidal vasculopathy a case report
url https://journalgrid.com/view/article/rjms/12434377
work_keys_str_mv AT mohans brolucizumabmonotherapyinidiopathicpolypoidalchoroidalvasculopathyacasereport
AT kalpanabadami brolucizumabmonotherapyinidiopathicpolypoidalchoroidalvasculopathyacasereport
AT shilpayd brolucizumabmonotherapyinidiopathicpolypoidalchoroidalvasculopathyacasereport
AT hemalatabc brolucizumabmonotherapyinidiopathicpolypoidalchoroidalvasculopathyacasereport